Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Company · Germany
Industry association · Belgium
Declared costs: €1.5M+ a year · in the register since 2016
European Centre for Disease Prevention and Control · European Medicines Agency
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
STADA · filed 2 Feb 2021 · source
As a member company of Medicines for Europe, STADA welcomes the reform of the mandate of the European Centre for Disease Control (ECDC) especially in light of its response to the first wave of the COVID-19 pandemic in Europe when it struggled to collect data from member states and to provide forecasts of the progression of the virus.
MedTech Europe · filed 2 Feb 2021 · source
MedTech Europe welcomes the objective and the proposed text on the extended role of the ECDC, as part of the European Health Union and suggestes to take the following considerations into account: 1. Involvement of Civil Society (Articles 5a and 5b): a.COVID-19 has demonstrated the need to involve the civil society in order to combat public health threats – in particular prevention, preparedness and response planning…
STADA · filed 2 Feb 2021 · source
STADA, taking into account to the lessons learned from COVID-19 crisis, believes that the proposal on management and mitigation of medicines shortages should be improved for better outcomes of the collaboration between the manufacturers and National and European medicines agencies to improve the supply of medicines to patients and to ensure EU solidarity.
MedTech Europe · filed 2 Feb 2021 · source
Regaring the proposed Regulation on the reinforced role of EMA, MedTech Europe suggests to take the following considerations into account (full position attached): 1. Involvement of Civil Society in the Executive Steering Committee on Medical Devices (Art19): a.COVID-19 has demonstrated the need to involve the medical technology industry and other partners of civil society in an ongoing dialogue throughout the full…
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.